DCF — ENCOMPASS HEALTH REHABILITATION HOSP
Enterprise Value: $44.3M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$44.3M
Enterprise Value
$12.2M
PV of Cash Flows
$32.1M
PV of Terminal Value
$51.6M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $33.5M | $5.2M | 15.0% | $2.7M | $2.4M |
| Year 2 | $34.5M | $5.7M | 16.0% | $3.0M | $2.5M |
| Year 3 | $35.5M | $6.2M | 17.0% | $3.4M | $2.5M |
| Year 4 | $36.6M | $6.6M | 18.0% | $3.6M | $2.5M |
| Year 5 | $37.7M | $6.8M | 18.0% | $3.8M | $2.3M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $44.3M. Terminal value accounts for 72% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$32.5M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.14933959491361845
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5